Alpine Immune Sciences Inc (ALPN.OQ)
ALPN.OQ on NASDAQ Stock Exchange Global Market
7.40USD
17 Apr 2018
7.40USD
17 Apr 2018
Change (% chg)
$-0.36 (-4.64%)
$-0.36 (-4.64%)
Prev Close
$7.76
$7.76
Open
$7.85
$7.85
Day's High
$7.85
$7.85
Day's Low
$7.37
$7.37
Volume
6,760
6,760
Avg. Vol
5,525
5,525
52-wk High
$12.82
$12.82
52-wk Low
$7.30
$7.30
About
Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $168.94 |
| Shares Outstanding(Mil.): | 13.88 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
BRIEF-Alpine Immune Sciences Provides Corporate Update And Reports Full Year 2017 Financial Results
* ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND REPORTS FULL YEAR 2017 FINANCIAL RESULTS
Estimates